Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Takeda Oncology
Biotech
Takeda inks sweet $1.2B-plus immuno-oncology deal with Kumquat
Takeda is offering Kumquat the chance to make $1.2-plus billion in a pact that centers around an unnamed immuno-oncology small-molecule inhibitor.
Gabrielle Masson
Apr 16, 2024 11:34am
Former CRISPR Tx CMO finds new home at Takeda
Feb 2, 2024 3:30pm
ASCO: Takeda Oncology ready to stoke partnerships
Jun 9, 2022 7:30am
